Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: J Pharm Biomed Anal. 2009 Dec 29;52(1):122. doi: 10.1016/j.jpba.2009.12.015

Figure 4.

Figure 4

Figure 4

Figure 4

Representative patient chromatograms of internal standard (top panel) and veliparib (bottom panel) (A) plasma C1D1 8 hr after veliparib administration, (B) bone marrow cells C1D4 5.25 hr after veliparib administration with 28 × 106 cell count, and (C) bone marrow supernatant C1D4 5.25 hr after veliparib administration.